Arlington Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Arlington Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Hold	644	–	–	0.04%	79
2026 Q1	$362K	Hold	644	–	–	0.05%	72
2025 Q4	$436K	Sell	644 -7	-1%	-$4.77K	0.06%	69
2025 Q3	$416K	Buy	651 +36	+6%	+$21.9K	0.06%	71
2025 Q2	$330K	Hold	615	–	–	0.05%	71
2025 Q1	$258K	Buy	615 +65	+12%	+$28.2K	0.05%	98
2024 Q4	$227K	Sell	550 -211	-28%	-$92.5K	0.05%	88
2024 Q3	$384K	Hold	761	–	–	0.08%	56
2024 Q2	$371K	Sell	761 -45	-6%	-$22.6K	0.08%	58
2024 Q1	$435K	Hold	806	–	–	0.1%	57
2023 Q4	$447K	Hold	806	–	–	0.13%	63
2023 Q3	$352K	Hold	806	–	–	0.12%	52
2023 Q2	$405K	Hold	806	–	–	0.15%	46
2023 Q1	$403K	Buy	806 +245	+44%	+$117K	0.16%	47
2022 Q4	$229K	Buy	+561	New	+$218K	0.1%	59
2022 Q1	–	Sell	-311	Closed	-$205K	–	67
2021 Q4	$205K	Buy	+311	New	+$195K	0.07%	75

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Arlington Financial Advisors's IDXX Position: Q2 2026 in Review

Arlington Financial Advisors held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 644 shares worth $339K. The position accounts for 0.04% of the portfolio, ranked #79.

Arlington Financial Advisors first reported a position in IDXX in Q4 2021 and has held it in 16 quarters since. The position peaked at $447K in Q4 2023. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Arlington Financial Advisors held 644 shares of Idexx Laboratories worth $339K as of Q2 2026.
Arlington Financial Advisors left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.04% of Arlington Financial Advisors's portfolio in Q2 2026, its #79 holding.
Arlington Financial Advisors first reported a position in Idexx Laboratories in Q4 2021 and has held it in 16 quarters since.
Arlington Financial Advisors's Idexx Laboratories position peaked at $447K in Q4 2023.
1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Arlington Financial Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.